Ethyl 6-bromo-4-chloroquinoline-3-carboxylate

CAS : 206257-39-8

Ref. 3D-FE130404

Informations sur le produit

• Nom: Ethyl 6-bromo-4-chloroquinoline-3-carboxylate
• Synonymes: 3-quinolinecarboxylic acid, 6-bromo-4-chloro-, ethyl ester, 3-Quinolinecarboxylic Acid, 6-Bromo-4-Chloro-, Ethyl Ester, Ethyl 6-bromo-4-chloro-3-quinolinecarboxylate
• CAS: 206257-39-8

Description

Ethyl 6-bromo-4-chloroquinoline-3-carboxylate is a drug that inhibits the activity of protein kinases. It has been shown to inhibit the activity of telangiectasia and is being investigated as a probe for medicinal chemistry. It is an analog of irinotecan, which inhibits the enzyme topoisomerase 1, leading to DNA damage. This drug also has potential as a cancer therapeutic because it is orally bioavailable and has been shown to be mutated in vivo, which may make it more effective at inhibiting tumor growth. Ethyl 6-bromo-4-chloroquinoline-3-carboxylate binds to ATP and prevents the release of ADP, which leads to inhibition of protein synthesis. This drug also inhibits tyrosine kinase activity by binding with carboxamides on the enzyme's active site.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 314.56 g/mol
• Formule: C₁₂H₉BrClNO₂
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C12H9BrClNO2/c1-2-17-12(16)9-6-15-10-4-3-7(13)5-8(10)11(9)14/h3-6H,2H2,1H3
• Code InChI: InChIKey=YGMLKBFPHVLHGT-UHFFFAOYSA-N
• SMILES: CCOC(=O)c1cnc2ccc(Br)cc2c1Cl